πŸ‡ΊπŸ‡Έ FDA
Patent

US 10202399

Dihydroxy aromatic heterocyclic compound

granted A61KA61K31/4412A61K31/4418

Quick answer

US patent 10202399 (Dihydroxy aromatic heterocyclic compound) held by Takeda Pharmaceutical Company Limited expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/4412, A61K31/4418, A61K31/4427, A61K31/443